Bidil

Product manufactured by Arbor Pharmaceuticals

Application Nr Approved Date Route Status External Links
NDA020727 2005-06-23 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Bidil Is Indicated For The Treatment Of Heart Failure As An Adjunct To Standard Therapy In Self-Identified Black Patients To Improve Survival, To Prolong Time To Hospitalization For Heart Failure, And To Improve Patient-Reported Functional Status. There Is Little Experience In Patients With Nyha Class Iv Heart Failure. Most Patients In The Clinical Trial Supporting Effectiveness (a-Heft) Received A Loop Diuretic, An Angiotensin Converting Enzyme Inhibitor Or An Angiotensin Ii Receptor Blocker, And A Beta Blocker, And Many Also Received A Cardiac Glycoside Or An Aldosterone Antagonist.

All Formulated Excipients (4 Total)

Name Structure Kind Function Status
1. Cellulose, Microcrystalline CELLULOSE, MICROCRYSTALLINE Unresolved
2. Silicon Dioxide SILICON DIOXIDE Unresolved AC-Anticaking agent , MISC-Miscellaneous , STAB-Stabilizer GRAS-Generally recognized as safe.
3. Magnesium Stearate MAGNESIUM STEARATE Molecular AF-Antifoaming (or defoaming) agent , MISC-Miscellaneous REG-Food additives for which a petition has been filed and a regulation issued.
4. Hypromelloses HYPROMELLOSES Unresolved

Active Ingredients ( 2 Total)

Comments